DOJ finalizes cannabis rescheduling to Schedule III, market reacts with caution

The Department of Justice finalized cannabis rescheduling to Schedule III. The Polymarket contract for weed rescheduled by December 31 sits at 44.8% YES, down from 62% yesterday.

Market reaction

Traders reacted quickly. The December 31 market dropped from 62% to 44.8%, suggesting mixed expectations about legal challenges or delays ahead. The June 30 contract fell harder, from 34% to 10.5%, showing strong skepticism about an earlier resolution.

Why it matters

The term structure is worth noting. A 34-point gap between the June 30 and December 31 contracts means traders expect any real progress later in the year. With 252 days until the December 31 resolution, legal and regulatory challenges have plenty of room to play out. The move to Schedule III benefits medical operators, but persistent bans on recreational use and interstate commerce limit the practical impact.

What to watch

Trading volume across these markets hit $96,741 in combined USDC over the past 24 hours. But it only takes $775 to move the December odds 5 percentage points, which means sharp swings are possible on thin order books. The largest move was an 8-point spike at 12:30 PM, showing how reactive the market is to new information.

Key catalysts ahead: the DEA’s June 29 hearing, any court rulings on temporary restraining orders, and official statements from Pam Bondi and Terrance Cole. At 45¢, buying YES shares offers a potential 2.22x return if rescheduling is verified by year-end. That bet requires confidence that no legal challenge derails the process before then.

API access

Get prediction market intelligence as a structured API feed. Early access waitlist.